IL43770A - Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them - Google Patents

Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL43770A
IL43770A IL43770A IL4377073A IL43770A IL 43770 A IL43770 A IL 43770A IL 43770 A IL43770 A IL 43770A IL 4377073 A IL4377073 A IL 4377073A IL 43770 A IL43770 A IL 43770A
Authority
IL
Israel
Prior art keywords
formula
compound
preparing
process according
tetrahydro
Prior art date
Application number
IL43770A
Other languages
English (en)
Hebrew (he)
Other versions
IL43770A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL43770A0 publication Critical patent/IL43770A0/xx
Publication of IL43770A publication Critical patent/IL43770A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL43770A 1972-12-08 1973-12-07 Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them IL43770A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US313285A US3865836A (en) 1972-12-08 1972-12-08 Bicyclic imidazoles

Publications (2)

Publication Number Publication Date
IL43770A0 IL43770A0 (en) 1974-03-14
IL43770A true IL43770A (en) 1976-08-31

Family

ID=23215116

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43770A IL43770A (en) 1972-12-08 1973-12-07 Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them

Country Status (23)

Country Link
US (1) US3865836A (US20090163788A1-20090625-C00002.png)
JP (1) JPS4994694A (US20090163788A1-20090625-C00002.png)
AT (1) AT333770B (US20090163788A1-20090625-C00002.png)
BE (1) BE808416A (US20090163788A1-20090625-C00002.png)
BG (1) BG21608A3 (US20090163788A1-20090625-C00002.png)
CA (1) CA1010864A (US20090163788A1-20090625-C00002.png)
CH (1) CH593975A5 (US20090163788A1-20090625-C00002.png)
DE (1) DE2361188A1 (US20090163788A1-20090625-C00002.png)
DK (1) DK141289B (US20090163788A1-20090625-C00002.png)
FI (1) FI54711C (US20090163788A1-20090625-C00002.png)
FR (1) FR2209576B1 (US20090163788A1-20090625-C00002.png)
GB (1) GB1446482A (US20090163788A1-20090625-C00002.png)
HU (1) HU168638B (US20090163788A1-20090625-C00002.png)
IE (1) IE38618B1 (US20090163788A1-20090625-C00002.png)
IL (1) IL43770A (US20090163788A1-20090625-C00002.png)
NL (1) NL7316778A (US20090163788A1-20090625-C00002.png)
NO (1) NO139087C (US20090163788A1-20090625-C00002.png)
PH (1) PH10417A (US20090163788A1-20090625-C00002.png)
PL (1) PL94683B1 (US20090163788A1-20090625-C00002.png)
RO (1) RO63263A (US20090163788A1-20090625-C00002.png)
SE (1) SE411627B (US20090163788A1-20090625-C00002.png)
SU (1) SU578003A3 (US20090163788A1-20090625-C00002.png)
ZA (1) ZA739343B (US20090163788A1-20090625-C00002.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG25138A1 (en) * 1977-07-06 1978-08-10 Georgiev A method of obtaining of rs-(+/-)-2,3,5,6-tetrahydro-6-phenylimidazo-(2,1-b)-thiazol(tetramizol)
HU181927B (en) * 1977-07-06 1983-11-28 Iso Pharmachim Process for producing r,s-2,3,5,6-tetrahydro-6-phenyl-imidazo-bracket-2,1-b-bracket closed thiazol /tetramizol/
DE2827617A1 (de) * 1978-06-23 1980-01-10 Boehringer Sohn Ingelheim Neue imidazo eckige klammer auf 1,2- alpha eckige klammer zu imidazole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
US4370500A (en) * 1978-11-06 1983-01-25 American Cyanamid Company Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization
DE3042636A1 (de) * 1980-11-12 1982-06-16 C.H. Boehringer Sohn, 6507 Ingelheim Neue 7-(2,6-dibrom-4-methylphenyl)-2,3-dihydro-imidazo(1,2-a)imidazole, deren saeureadditionssalze, diese enhthaltende arzneimittel und verfahren zu deren herstellung
GB8509531D0 (en) * 1985-04-13 1985-05-15 Bp Chem Int Ltd Preparation of guanidines
US6359144B1 (en) * 1997-02-04 2002-03-19 Lion Bioscience Ag Combinatorial libraries of bicyclic guanidine derivatives and compounds therein
EP1359916A4 (en) * 2001-01-26 2004-04-07 Bristol Myers Squibb Co IMIDAZOLYLATED DERIVATIVES AS INHIBITORS OF CORTICOTROPIN RELEASE FACTOR
ES2250721T3 (es) * 2001-09-21 2006-04-16 Sanofi-Aventis Derivados de 2-pirimidinil-6,7,8,9-tetrahidropirimido(1,2-a)pirimidin-4-ona y 7-pirimidinil-2,3-dihidroimidazo(1,2-a)pirimidin-5(1h)ona sustituidos para enfermedades neurodegenerativas.
EP1896477B1 (en) * 2005-06-14 2010-09-22 Schering Corporation Aspartyl protease inhibitors
US8563560B2 (en) * 2011-02-25 2013-10-22 Ppg Industries Ohio, Inc. Preparation of bicyclic guanidine salts in an aqueous media

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB796996A (en) * 1956-03-29 1958-06-25 Monsanto Canada Ltd Imidazole derivatives
GB805877A (en) * 1957-01-28 1958-12-17 Monsanto Canada Ltd Process for the production of 2, 3, 5, 6-tetrahydro-1-imidaz (1, 2-a) imidazole

Also Published As

Publication number Publication date
PH10417A (en) 1977-03-16
SU578003A3 (ru) 1977-10-25
NO139087B (no) 1978-09-25
NO139087C (no) 1979-01-03
FI54711C (fi) 1979-02-12
IL43770A0 (en) 1974-03-14
AT333770B (de) 1976-12-10
US3865836A (en) 1975-02-11
RO63263A (fr) 1978-08-15
DK141289B (da) 1980-02-18
JPS4994694A (US20090163788A1-20090625-C00002.png) 1974-09-09
HU168638B (US20090163788A1-20090625-C00002.png) 1976-06-28
BE808416A (fr) 1974-06-10
ZA739343B (en) 1975-07-30
IE38618B1 (en) 1978-04-26
AU6337173A (en) 1975-06-12
DK141289C (US20090163788A1-20090625-C00002.png) 1980-08-11
FI54711B (fi) 1978-10-31
FR2209576A1 (US20090163788A1-20090625-C00002.png) 1974-07-05
GB1446482A (en) 1976-08-18
IE38618L (en) 1974-06-08
NL7316778A (US20090163788A1-20090625-C00002.png) 1974-06-11
CH593975A5 (US20090163788A1-20090625-C00002.png) 1977-12-30
FR2209576B1 (US20090163788A1-20090625-C00002.png) 1977-01-28
ATA1026573A (de) 1976-04-15
BG21608A3 (US20090163788A1-20090625-C00002.png) 1976-07-20
SE411627B (sv) 1980-01-21
CA1010864A (en) 1977-05-24
DE2361188A1 (de) 1974-06-12
PL94683B1 (pl) 1977-08-31

Similar Documents

Publication Publication Date Title
IL43770A (en) Imidazo] a - 2, 1 [Imidazoles, Imidazo] a - 2, 1 [pyramidines, and pyrimido] a - 2, 1 [pyramidines, their preparation and pharmaceutical preparations containing them
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
KR950005825A (ko) 4-아미노피리미딘 유도체
PL335685A1 (en) Pyrrole[2,3-d]pyrimidines and their application as inhibitors of tyrosine kinase
HUT40798A (en) Process for producing new, heterocyclic imidazol derivatives and pharmaceutically acceptable acid additional salts thereof
FI113265B (fi) Menetelmä uusien, verihiutaleiden aggregaatiota estävien 2,5-dioksoimidatsolidinyylijohdannaisten valmistamiseksi
EP1832590B8 (en) Heterotricyclic compounds as CRF receptor antagonists
CA2278331A1 (en) 3-heterocyclyl-substituted benzoyl derivatives
EP1156045A4 (en) AMID DERIVATIVES AND DRUG COMPOSITIONS
CA2293621A1 (en) 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
KR920008031A (ko) 퀴나졸린 유도체 및 그의 제조방법
WO2001014379A3 (en) A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
AU7581996A (en) 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists
CA2084490A1 (en) Process for the preparation of pyrrolo[2,3-d]pyrimidines
AU4629796A (en) 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist
IE870128L (en) Dihydrobenzofuran and chroman - carboxamides
CA2196263A1 (en) Process for the preparation of 4-oxoimidazolinium salts
CA2366624A1 (en) 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents
PL337279A1 (en) Pharmaceutical with controlled releose containing inhibitor ace as an active substance
EP1430898A4 (en) RECEPTOR ANTAGONIST
WO1997027173A3 (en) Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production
CA2376668A1 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
CA2278057A1 (en) Tachykinin antagonists
YU82493A (sh) Novi postupak za dobivanje sumpornih derivata imidazola i dobiveni intermedijeri
UA72923C2 (uk) Заміщені похідні пурину як інгібітори клітинної адгезії